Anidulafungin0 vendors competing

No vendor pricing available for this peptide yet.

Research details

Anidulafungin — research data

Regulatory statusFDA-approved (Eraxis)
NCAA D1Permitted

Overview

About Anidulafungin

Mechanism of action

Echinocandin antifungal; non-competitive beta-1,3-glucan synthesis inhibitor unique chemical structure

Safety profile

Hepatitis risk, rash, GI symptoms, histamine-like reactions · Well-established IV antifungal; rare hepatotoxicity; generally well-tolerated

Related pages

More on Anidulafungin

Failed to fetch